Prognostic Value of Serum Albumin at Admission for Neurologic Outcome with Targeted Temperature Management after Cardiac Arrest

Table 2

Comparison of patients according to 6-month neurologic outcome.

	Good neurologic outcome (n = 84)	Poor neurologic outcome (n = 171)
Demographics
Male	64 (76.2)	116 (67.8)	0.169
Age, years	48.3 ± 15.2	57.9 ± 16.5	<0.001
Comorbidities
CAD	12 (14.3)	19 (11.1)	0.466
CHF	3 (3.6)	5 (2.9)	0.721
Stroke	0 (0.0)	5 (2.9)	0.175
Hypertension	16 (19.0)	60 (35.1)	0.008
Diabetes mellitus	5 (6.0)	50 (29.2)	<0.001
Renal disease	0 (0.0)	17 (9.9)	0.001
Liver disease	0 (0.0)	2 (1.2)	0.449
Malignancy	1 (1.2)	10 (5.8)	0.074
Resuscitation variables
Cardiac cause	79 (94.0)	96 (56.1)	<0.001
Shockable rhythm	68 (81.0)	30 (17.5)	<0.001
Witnessed	72 (85.7)	110 (64.7)	<0.001
Bystander CPR	52 (61.9)	90 (52.9)	0.176
Anoxic time (min)	23.6 ± 15.0	38.6 ± 20.3	<0.001
Post-ROSC N/Ex
PLR	64 (76.2)	31 (18.1)	<0.001
Self-respiration	73 (86.9)	58 (33.9)	<0.001
GCS motor, yes	47 (56.0)	13 (7.6)	<0.001
Hemodynamic status
MAP	99.2 ± 25.2	87.6 ± 26.9	0.001
HR	101.2 ± 25.7	104.3 ± 28.4	0.407
Temperature	35.8 ± 0.9	35.5 ± 1.4	0.060
Hypoalbuminemia	14 (16.7)	95 (55.6)	<0.001
Albumin (mg/dl)	3.9 ± 0.4	3.3 ± 0.6	<0.001
Outcomes
Pneumonia	26 (31.0)	83 (48.5)	0.008
Septic shock	4 (4.8)	22 (12.9)	0.049
HD (days)	7 (4–20)	15 (9–23)	<0.001